+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
New

Wellness Genomics Market Size and Share Outlook - Forecast Trends and Growth Analysis Report (2025-2034)

  • PDF Icon

    Report

  • 400 Pages
  • June 2025
  • Region: Global
  • Expert Market Research
  • ID: 6016006
The global wellness genomics market size reached around USD 5.44 Billion in 2024. The market is projected to grow at a CAGR of 15.10% between 2025 and 2034 to reach nearly USD 22.20 Billion by 2034.

Wellness Genomics Market Overview

Wellness genomics utilizes genetic information and genomic technologies to offer insights into various aspects of health. It helps in preventing potential health issues and improving personal health outcomes. The market is driven by the rising interest in personalized health and wellness among the general population. The advancements in genomic technologies have made genetic testing more affordable and the results more accurate and reliable, which also contributes the market growth. The rising popularity of direct-to-consumer (DTC) genetic testing kits marketed by companies like 23andMe and AncestryDNA is anticipated to aid market expansion. Additionally, increased funding for research and development in genomics is leading to new findings and applications in the wellness sector. Further, heightened awareness about the importance of preventive healthcare, rising partnerships between genetic testing companies, and expansion of genomics in the skincare and beauty sector are some of the factors that are influencing the market growth.

Wellness Genomics Market Growth Drivers

Rise in the Launch of Genomic-Based Tests for Preventive Wellness to Impact Market Growth

In November 2022, Strand Life Sciences, a company specializing in genomics-based research and diagnostics, announced the launch of a new product series of genomic-based tests for preventive wellness called Strand Genomic Wellness at the Bengaluru Tech Summit. Strand’s new offering is aimed at helping people understand and manage their disease in a better way. Similarly, the GenepoweRx wellness test called Total GenepoweRx Total helps to identify the risk of vitamin deficiencies, change dietary patterns, and make informed lifestyle decisions to achieve wellness goals. The rising introduction of such innovative genomic-based tests is anticipated to support the market growth.

Wellness Genomics Market Trends

The market is witnessing several trends and developments to improve the current global scenario. Some of the notable trends are as follows:

Growing Demand for Personalized Health and Wellness Solutions Likely to Affect the Market Landscape

The market is witnessing a growing consumer interest in personalized health and wellness, which is leading to significant demand for wellness genomics offerings. People are increasingly looking for customized solutions that are aligned with their genetic profiles. Insights from genomic profiling can provide personalized recommendations for nutrition, exercise, and preventive healthcare, among others.

Advancements in Genomic Technologies to Augment Wellness Genomics Market Demand

One of the significant market trends is the rising advancements in genomic technologies which has made genetic testing affordable as well as more reliable. The development of next-generation sequencing (NGS) and other advanced techniques help in generating in-depth insights regarding health and wellness aspects. Thus, technological improvements are leading to the rise in the adoption of genomic-based wellness products and services.

Heightened Awareness of Preventive Healthcare Poised to Elevate the Wellness Genomics Market Value

The growing awareness among the public about the importance of preventive healthcare has increased their interest in genomic testing for early detection and prevention of health conditions. Wellness genomics helps in developing preventive strategies based on the individual's genetic makeup if a genetic predisposition to a certain health condition is indicated. These preventive measures can range from adopting specific dietary changes and exercise regimens to making lifestyle modifications. Thus, the increased focus on the prevention of diseases is likely to elevate the market value.

Growth in Direct-to-Consumer (DTC) Genomics to Boost Wellness Genomics Market Size

The rise of direct-to-consumer (DTC) genomics is a significant market trend that is projected to boost the market size. DTC genomics allows consumers to access genetic tests without the involvement of a healthcare provider, which makes the offerings accessible to a wider audience. Further, companies like 23andMe and AncestryDNA offer easy-to-use and affordable genetic testing kits, which also generate substantial demand in the market. Moreover, DTC genomics companies are increasingly investing in consumer education and engagement, which is likely to increase the sales of wellness genomics products.

Wellness Genomics Market Segmentation

The report titled “Wellness Genomics Market Report and Forecast 2025-2034” offers a detailed analysis of the market based on the following segments:

Market Breakup by Type

  • Predictive Testing
  • Predictive Diagnostic
  • Population Screening Programs
  • Others
  • Consumer Genomics
  • Wellness Genetics
  • Skin and Metabolism Genetics
  • Others

Market Breakup by Setting Type

  • Direct-to-Consumer (DTC)
  • Professionals

Market Breakup by Application

  • Cancer Screening
  • Cardiovascular Screening
  • Diabetic Screening and Monitoring
  • Alzheimer’s Disease
  • Orthopedic and Musculoskeletal Screening
  • Others

Market Breakup by Region

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East and Africa

Wellness Genomics Market Share

The Type Segment Holds a Significant Market Share

Based on the type of wellness genomics, the market is segmented into predictive testing and consumer genomics. Predictive testing further includes predictive diagnostics, population screening programs, and others, whereas consumer genomics is segmented into wellness genetics, skin and metabolism genetics, and others. The consumer genomics segment is witnessing significant market demand owing to the rising availability of direct-to-consumer genetic testing services. Further, consumer genomics tests are generally more affordable and convenient compared to predictive diagnostic tests which also contributes to their increasing adoption. Moreover, the rising disposable income and awareness of personalized healthcare are poised to fuel the growth of this segment.

Global Wellness Genomics Market Analysis by Region

North America holds the largest share of the market driven by the widespread adoption of consumer genomics and substantial investment in research and development. In countries like the United States, the increasing disposable incomes and the availability of direct-to-consumer (DTC) genetic testing also support market growth. Moreover, the presence of a positive regulatory environment, maintained by health agencies such as the US Food and Drug Administration (FDA), also stimulates the market expansion in the region.

Leading Players in the Global Wellness Genomics Market

The key features of the market report comprise patent analysis, grants analysis, funding and investment analysis, and strategic initiatives by the leading key players. The major companies in the market are as follows:

NMC Genetics

NMC Genetics is a prominent player in the market, which is recognized for its advanced genetic testing services including wellness-focused tests related to nutrition, fitness, and lifestyle management.

OhMyGene

This genomics-driven molecular diagnostic company specializes in offering clinical and personalized genomic test services. OhMyGene is also known for its easy-to-understand reports and focus on personalized wellness.

GenepoweRx

GenepoweRx, a leading genome profiling company, is a key player in the wellness genomics market. The company is known for its expertise in predictive genomics, offering tests that can help analyze genetic predispositions to various diseases.

Strand

Indian in silico technology company, Strand Life Sciences (which was formerly known as Strand Genomics) specializes in wellness genomics, oncology genomics, and personalized medicine. Its wellness genomic tests offer insights into nutrition, fitness, and predispositions to health conditions.

Other key players in the market include Tania Flack Naturopath, PT Prodia Widyahusada Tbk, Providence, and Variantyx Inc.

Key Questions Answered in the Global Wellness Genomics Market Report

  • What was the global wellness genomics market value in 2024?
  • What is the global wellness genomics market forecast outlook for 2025-2034?
  • What are the regional markets covered in the report?
  • What is market segmentation based on type?
  • What is the market breakup based on setting type?
  • What is the market breakup by application?
  • What are the major factors aiding the global wellness genomics market demand?
  • How has the market performed so far and how is it anticipated to perform in the coming years?
  • What are the market's major drivers, opportunities, and restraints?
  • Which regional market is expected to lead the market share in the forecast period?
  • Which country is expected to experience expedited growth during the forecast period?
  • How do the advancements in genomic technologies affect the market landscape?
  • What are the major global wellness genomics market trends?
  • How does the rising investment in genomic wellness impact the market size?
  • Which type of wellness genomics will dominate the market share?
  • Which application is expected to have a high market value in the coming years?
  • Which setting type will experience the highest demand in the market segment?
  • Who are the key players involved in the wellness genomics market?
  • What is the patent landscape of the market?
  • What are the current unmet needs and challenges in the market?
  • How are partnerships, collaborations, and mergers & acquisitions among the key market players shaping the market dynamics?

This product will be delivered within 3-5 business days.

Table of Contents

1 Preface
1.1 Objectives of the Study
1.2 Key Assumptions
1.3 Report Coverage - Key Segmentation and Scope
1.4 Research Methodology
2 Executive Summary
3 Global Wellness Genomics Market Overview
3.1 Global Wellness Genomics Market Historical Value (2018-2024)
3.2 Global Wellness Genomics Market Forecast Value (2025-2034)
4 Global Wellness Genomics Market Landscape*
4.1 Global Wellness Genomics Market: Developers Landscape
4.1.1 Analysis by Year of Establishment
4.1.2 Analysis by Company Size
4.1.3 Analysis by Region
4.2 Global Wellness Genomics Market: Service Landscape
4.2.1 Analysis by Type
4.2.2 Analysis by Application
5 Global Wellness Genomics Market Dynamics
5.1 Market Drivers and Constraints
5.2 SWOT Analysis
5.2.1 Strengths
5.2.2 Weaknesses
5.2.3 Opportunities
5.2.4 Threats
5.3 PESTEL Analysis
5.3.1 Political
5.3.2 Economic
5.3.3 Social
5.3.4 Technological
5.3.5 Legal
5.3.6 Environment
5.4 Porter’s Five Forces Model
5.4.1 Bargaining Power of Suppliers
5.4.2 Bargaining Power of Buyers
5.4.3 Threat of New Entrants
5.4.4 Threat of Substitutes
5.4.5 Degree of Rivalry
5.5 Key Demand Indicators
5.6 Key Price Indicators
5.7 Industry Events, Initiatives, and Trends
5.8 Value Chain Analysis
6 Global Wellness Genomics Market Segmentation (218-2034)
6.1 Global Wellness Genomics Market (2018-2034) by Type
6.1.1 Market Overview
6.1.2 Predictive Testing
6.1.2.1 Predictive Diagnostic
6.1.2.2 Population Screening Programs
6.1.2.3 Others
6.1.3 Consumer Genomics
6.1.3.1 Wellness Genetics
6.1.3.2 Skin and Metabolism Genetics
6.1.3.3 Others
6.2 Global Wellness Genomics Market (2018-2034) by Setting Type
6.2.1 Market Overview
6.2.2 Direct-to-Consumer (DTC)
6.2.3 Professionals
6.3 Global Wellness Genomics Market (2018-2034) by Application
6.3.1 Market Overview
6.3.2 Cancer Screening
6.3.3 Cardiovascular Screening
6.3.4 Diabetic Screening and Monitoring
6.3.5 Alzheimer Disease
6.3.6 Orthopedic and Musculoskeletal Screening
6.3.7 Others
6.4 Global Wellness Genomics Market (2018-2034) by Region
6.4.1 Market Overview
6.4.2 North America
6.4.3 Europe
6.4.4 Asia Pacific
6.4.5 Latin America
6.4.6 Middle East and Africa
7 North America Wellness Genomics Market (218-2034)
7.1 North America Wellness Genomics Market (2018-2034) by Type
7.1.1 Market Overview
7.1.2 Predictive Testing
7.1.2.1 Predictive Diagnostic
7.1.2.2 Population Screening Programs
7.1.2.3 Others
7.1.3 Consumer Genomics
7.1.3.1 Wellness Genetics
7.1.3.2 Skin and Metabolism Genetics
7.1.3.3 Others
7.2 North America Wellness Genomics Market (2018-2034) by Setting Type
7.2.1 Market Overview
7.2.2 Direct-to-Consumer (DTC)
7.2.3 Professionals
7.3 North America Wellness Genomics Market (2018-2034) by Application
7.3.1 Market Overview
7.3.2 Cancer Screening
7.3.3 Cardiovascular Screening
7.3.4 Diabetic Screening and Monitoring
7.3.5 Alzheimer Disease
7.3.6 Orthopedic and Musculoskeletal Screening
7.3.7 Others
7.4 North America Wellness Genomics Market (2018-2034) by Country
7.4.1 United States of America
7.4.2 Canada
8 Europe Wellness Genomics Market (218-2034)
8.1 Europe Wellness Genomics Market (2018-2034) by Type
8.1.1 Market Overview
8.1.2 Predictive Testing
8.1.2.1 Predictive Diagnostic
8.1.2.2 Population Screening Programs
8.1.2.3 Others
8.1.3 Consumer Genomics
8.1.3.1 Wellness Genetics
8.1.3.2 Skin and Metabolism Genetics
8.1.3.3 Others
8.2 Europe Wellness Genomics Market (2018-2034) by Setting Type
8.2.1 Market Overview
8.2.2 Direct-to-Consumer (DTC)
8.2.3 Professionals
8.3 Europe Wellness Genomics Market (2018-2034) by Application
8.3.1 Market Overview
8.3.2 Cancer Screening
8.3.3 Cardiovascular Screening
8.3.4 Diabetic Screening and Monitoring
8.3.5 Alzheimer Disease
8.3.6 Orthopedic and Musculoskeletal Screening
8.3.7 Others
8.4 Europe Wellness Genomics Market (2018-2034) by Country
8.4.1 United Kingdom
8.4.2 Germany
8.4.3 France
8.4.4 Italy
8.4.5 Others
9 Asia Pacific Wellness Genomics Market (218-2034)
9.1 Asia Pacific Wellness Genomics Market (2018-2034) by Type
9.1.1 Market Overview
9.1.2 Predictive Testing
9.1.2.1 Predictive Diagnostic
9.1.2.2 Population Screening Programs
9.1.2.3 Others
9.1.3 Consumer Genomics
9.1.3.1 Wellness Genetics
9.1.3.2 Skin and Metabolism Genetics
9.1.3.3 Others
9.2 Asia Pacific Wellness Genomics Market (2018-2034) by Setting Type
9.2.1 Market Overview
9.2.2 Direct-to-Consumer (DTC)
9.2.3 Professionals
9.3 Asia Pacific Wellness Genomics Market (2018-2034) by Application
9.3.1 Market Overview
9.3.2 Cancer Screening
9.3.3 Cardiovascular Screening
9.3.4 Diabetic Screening and Monitoring
9.3.5 Alzheimer Disease
9.3.6 Orthopedic and Musculoskeletal Screening
9.3.7 Others
9.4 Asia Pacific Wellness Genomics Market (2018-2034) by Country
9.4.1 China
9.4.2 Japan
9.4.3 India
9.4.4 ASEAN
9.4.5 Australia
9.4.6 Others
10 Latin America Wellness Genomics Market (218-2034)
10.1 Latin America Wellness Genomics Market (2018-2034) by Type
10.1.1 Market Overview
10.1.2 Predictive Testing
10.1.2.1 Predictive Diagnostic
10.1.2.2 Population Screening Programs
10.1.2.3 Others
10.1.3 Consumer Genomics
10.1.3.1 Wellness Genetics
10.1.3.2 Skin and Metabolism Genetics
10.1.3.3 Others
10.2 Latin America Wellness Genomics Market (2018-2034) by Setting Type
10.2.1 Market Overview
10.2.2 Direct-to-Consumer (DTC)
10.2.3 Professionals
10.3 Latin America Wellness Genomics Market (2018-2034) by Application
10.3.1 Market Overview
10.3.2 Cancer Screening
10.3.3 Cardiovascular Screening
10.3.4 Diabetic Screening and Monitoring
10.3.5 Alzheimer Disease
10.3.6 Orthopedic and Musculoskeletal Screening
10.3.7 Others
10.4 Latin America Wellness Genomics Market (2018-2034) by Country
10.4.1 Brazil
10.4.2 Argentina
10.4.3 Mexico
10.4.4 Others
11 Middle East and Africa Wellness Genomics Market (218-2034)
11.1 Middle East and Africa Wellness Genomics Market (2018-2034) by Type
11.1.1 Market Overview
11.1.2 Predictive Testing
11.1.2.1 Predictive Diagnostic
11.1.2.2 Population Screening Programs
11.1.2.3 Others
11.1.3 Consumer Genomics
11.1.3.1 Wellness Genetics
11.1.3.2 Skin and Metabolism Genetics
11.1.3.3 Others
11.2 Middle East and Africa Wellness Genomics Market (2018-2034) by Setting Type
11.2.1 Market Overview
11.2.2 Direct-to-Consumer (DTC)
11.2.3 Professionals
11.3 Middle East and Africa Wellness Genomics Market (2018-2034) by Application
11.3.1 Market Overview
11.3.2 Cancer Screening
11.3.3 Cardiovascular Screening
11.3.4 Diabetic Screening and Monitoring
11.3.5 Alzheimer Disease
11.3.6 Orthopedic and Musculoskeletal Screening
11.3.7 Others
11.4 Middle East and Africa Wellness Genomics Market (2018-2034) by Country
11.4.1 Saudi Arabia
11.4.2 United Arab Emirates
11.4.3 Nigeria
11.4.4 South Africa
11.4.5 Others
12 Regulatory Framework
12.1 Regulatory Overview
12.2 US FDA
12.3 EU EMA
12.4 INDIA CDSCO
12.5 JAPAN PMDA
12.6 Others
13 Patent Analysis
13.1 Analysis by Type of Patent
13.2 Analysis by Publication Year
13.3 Analysis by Issuing Authority
13.4 Analysis by Patent Age
13.5 Analysis by CPC Analysis
13.6 Analysis by Patent Valuation
13.7 Analysis by Key Players
14 Grants Analysis
14.1 Analysis by Year
14.2 Analysis by Amount Awarded
14.3 Analysis by Issuing Authority
14.4 Analysis by Grant Application
14.5 Analysis by Funding Institute
14.6 Analysis by Departments
14.7 Analysis by Recipient Organization
15 Funding and Investment Analysis
15.1 Analysis by Funding Instances
15.2 Analysis by Type of Funding
15.3 Analysis by Funding Amount
15.4 Analysis by Leading Players
15.5 Analysis by Leading Investors
15.6 Analysis by Geography
16 Strategic Initiatives
16.1 Analysis by Partnership Instances
16.2 Analysis by Type of Partnership
16.3 Analysis by Leading Players
16.4 Analysis by Geography
17 Service Provider Landscape
17.1 Market Share Analysis, By Region (Top 5 Companies)
17.2 Tania Flack Naturopath
17.2.1 Financial Analysis
17.2.2 Service Portfolio
17.2.3 Demographic Reach and Achievements
17.2.4 Company News and Developments
17.2.5 Certifications
17.3 PT Prodia Widyahusada Tbk
17.3.1 Financial Analysis
17.3.2 Service Portfolio
17.3.3 Demographic Reach and Achievements
17.3.4 Company News and Developments
17.3.5 Certifications
17.4 NMC Genetics
17.4.1 Financial Analysis
17.4.2 Service Portfolio
17.4.3 Demographic Reach and Achievements
17.4.4 Company News and Developments
17.4.5 Certifications
17.5 OhMyGene
17.5.1 Financial Analysis
17.5.2 Service Portfolio
17.5.3 Demographic Reach and Achievements
17.5.4 Company News and Developments
17.5.5 Certifications
17.6 GenepoweRx
17.6.1 Financial Analysis
17.6.2 Service Portfolio
17.6.3 Demographic Reach and Achievements
17.6.4 Company News and Developments
17.6.5 Certifications
17.7 Strand
17.7.1 Financial Analysis
17.7.2 Service Portfolio
17.7.3 Demographic Reach and Achievements
17.7.4 Company News and Developments
17.7.5 Certifications
17.8 Providence
17.8.1 Financial Analysis
17.8.2 Service Portfolio
17.8.3 Demographic Reach and Achievements
17.8.4 Company News and Developments
17.8.5 Certifications
17.9 Variantyx Inc.
17.9.1 Financial Analysis
17.9.2 Service Portfolio
17.9.3 Demographic Reach and Achievements
17.9.4 Company News and Developments
17.9.5 Certifications
18 Global Wellness Genomics Market - Distribution Model (Additional Insight)
18.1 Overview
18.2 Potential Distributors
18.3 Key Parameters for Distribution Partner Assessment
19 Key Opinion Leaders (KOL) Insights (Additional Insight)

Companies Mentioned

  • NMC Genetics
  • OhMyGene
  • GenepoweRx
  • Strand

Table Information